Day: December 18, 2023

Dragonfly Energy Partners with Connexa, Fueling Industrial Solar Power System Applications

Written by Customer Service on December 18, 2023. Posted in Public Companies.

Dragonfly Energy CEO, Dr. Denis Phares with Connexa Founder, Mike PostelDragonfly Energy CEO, Dr. Denis Phares with Connexa Founder, Mike PostelDragonfly Energy partners with Connexa, supplying lithium batteries to power Connexa’s industrial solar power systems This relationship signifies another significant opportunity for Dragonfly Energy to expand into the industrial solar industry marketRENO, Nev., Dec. 18, 2023 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), maker of Battle Born Batteries™ and an industry leader in energy storage, is now supplying lithium batteries to Connexa Energy Company (“Connexa”), a manufacturer and distributor of remote and industrial solar energy products. Connexa will be including Dragonfly Energy’s Battle Born Batteries products...

Salona Global Announces the Debut of the Biodex Reactive Step Trainer, a Revolutionary Balance Training System to Reduce Falls; Commences AI Enabled Software Component

Written by Customer Service on December 18, 2023. Posted in Public Companies.

NEW YORK, Dec. 18, 2023 (GLOBE NEWSWIRE) — Salona Global Medical Device Corporation (the ‎‎‎“Company”) (TSXV:SGMD), announced today the debut of the Biodex Reactive Step Trainer (“RST”): A revolutionary medical device that combines Biodex Rehab’s industry leading gait trainer platform with a clinically proven perturbation training system. There is a critical need for a proactive approach to fall prevention as the world’s population is aging1. One in three people over the age of 65 experience at least one fall each year and those falls are the leading cause of fatal and nonfatal injuries in older adults2. The RST can help by retraining the neuromuscular system to respond when a person becomes off balance, with the aim of creating muscle memory when recovering from a trip or slip in a controlled environment. The Company plans to...

ExxonMobil to Build CCS Pilot Plant with FuelCell Energy Using Carbonate Fuel Cell Technology

Written by Customer Service on December 18, 2023. Posted in Public Companies.

First time for carbonate fuel cell technology to be piloted for carbon capture in an industrial environment Captured CO2 will be transported and stored via the Porthos project for permanent storage under the North Sea If successful, the technology would be commercialized to reduce emissions at ExxonMobil locations and other industrial sites to help customers reduce their emissionsROTTERDAM, Netherlands and DANBURY, Conn., Dec. 18, 2023 (GLOBE NEWSWIRE) — ExxonMobil’s affiliate Esso Nederland BV plans to build a pilot plant at its Rotterdam Manufacturing Complex to test a breakthrough technology that could significantly reduce CO2 emissions from key industries. The pilot plant aims to obtain data on performance and operability of the carbonate fuel cell (CFC) technology, jointly developed with FuelCell Energy. Additionally, the...

BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation Minutes

Written by Customer Service on December 18, 2023. Posted in Public Companies.

SUNNYVALE, Calif., Dec. 18, 2023 (GLOBE NEWSWIRE) — BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that Japan Pharmaceutical and Medical Device Agency (PMDA) minutes support the Company’s understanding that CardiAMP autologous cell therapy may be approved for the treatment of patients with ischemic heart failure with reduced ejection fraction (HFrEF) based on follow-up data from the patients currently enrolled in the CardiAMP Heart Failure Trial (CardiAMP HF) that will be available in Q4 2024. BioCardia has previously reported that although the primary endpoint of CardiAMP HF would most likely not have been met at one year; there was both reduced mortality and reduced major adverse cardiovascular events in treated...

IntelGenx Announces New Animal Health Partnership; Enters into Development and License Agreements for VetaFilm®

Written by Customer Service on December 18, 2023. Posted in Public Companies.

SAINT LAURENT, Quebec, Dec. 18, 2023 (GLOBE NEWSWIRE) — IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) today announced that it has entered into development and license agreements (collectively the “Agreements”) with a wholly-owned subsidiary of Covenant Animal Health Partners, LLC (“Covenant Animal Health”). Under the terms of the development agreement, Covenant Animal Health will fund development and manufacturing of a VetaFilm®-based drug (the “Product”). The license agreement will give Covenant Animal Health exclusive rights to exploit the Product in the field for non-human applications. In return, IntelGenx will receive royalties on worldwide net sales of the Product. IntelGenx will manufacture the Product on worldwide basis for clinical development, and the parties anticipate...

Unicycive Therapeutics Announces Enrollment of First Patient in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) in Patients with Chronic Kidney Disease on Dialysis

Written by Customer Service on December 18, 2023. Posted in Public Companies.

Study will Evaluate 60 Participants with Results Expected in Q2 2024 LOS ALTOS, Calif., Dec. 18, 2023 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today announced the enrollment of the first patient in its open-label, single-arm, multicenter, multidose pivotal clinical trial with Oxylanthanum Carbonate (OLC). OLC is a next-generation lanthanum-based phosphate binding agent utilizing proprietary nanoparticle technology being developed for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. “The initiation of patient enrollment in our OLC pivotal clinical trial is a critical milestone as we strive to reduce the pill burden and improve quality of life...

Reflux Testing Products Market Size Worth USD 4.56 Billion in 2032 | Emergen Research

Written by Customer Service on December 18, 2023. Posted in Mergers And Acquisitions.

Rising prevalence of Gastroesophageal Reflux Disease (GERD) is a major factor driving reflux testing products market revenue growth Vancouver, Dec. 18, 2023 (GLOBE NEWSWIRE) — The global reflux testing products market size was USD 3.04 Billion in 2022 and is expected to register a revenue CAGR of 4.1% during the forecast period, according to the latest analysis by Emergen Research. Rising prevalence of Gastroesophageal Reflux Disease (GERD), technological advancements in diagnostics, and increasing initiatives and product launches by leading companies are some of the major factors driving the market revenue growth. In addition, rising demand for minimally invasive techniques is also contributing to the market revenue growth. Rising prevalence of Gastroesophageal Reflux Disease (GERD) is a major factor driving revenue growth of...

Automotive Grade Inductors Market Size Worth USD 3,864.7 Million in 2032 | Emergen Research

Written by Customer Service on December 18, 2023. Posted in Mergers And Acquisitions.

Increasing need for integrating technology in the automotive industry is a key factor driving automotive grade inductors market revenue growth Vancouver, Dec. 18, 2023 (GLOBE NEWSWIRE) — The global automotive grade inductors market size was USD 2,803.5 Million in 2022 and is expected to register a steady revenue CAGR of 3.3% during the forecast period, according to latest analysis by Emergen Research. Rapid advancements in automotive infotainments and rising demand for EVs are key factors driving market revenue growth. Automotive-grade inductors provide high-frequency filtering, impedance matching, and Radiofrequency (RF) tuned circuits in automotive transmission within a vehicle. In addition, rising demand for Advanced Driver Assistance Systems (ADAS), increasing adoption of EVs, and rapid advancement of sophisticated infotainment...

Mmwave Antenna Module Market Growth CAGR 11.3% During 2022-2032 | Emergen Research

Written by Customer Service on December 18, 2023. Posted in Mergers And Acquisitions.

Rising usage of mmwave antenna modules in Fifth Generation (5G) wireless backhaul technology is a key factor driving Mmwave Antenna Module Market revenue growth Vancouver, Dec. 18, 2023 (GLOBE NEWSWIRE) — The global mmwave antenna module market size reached USD XX billion in 2022 and is expected to register a steady revenue CAGR of 11.3 % during the forecast period, according to latest analysis by Emergen Research. Rising demand for mmWave antennas in various applications, such as cell phones, communication devices, vehicular systems, and tablet Personal Computer (PCs) is a key factor driving market revenue growth.MmWave frequencies have higher bandwidth than lower frequency bands, which are utilized in traditional wireless backhaul. This increased capacity allows for faster data transfer of large amounts of data, which is essential...

Himax to Debut Industry Leading In-Cell TDDI for LCD Notebook and On-Cell Touch Controller for Premium AMOLED Notebook at CES 2024

Written by Customer Service on December 18, 2023. Posted in Public Companies.

TAINAN, Taiwan, Dec. 18, 2023 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced the Company will debut industry leading in-cell TDDI, HX83132 series, for prevailing LCD notebook, and the on-cell touch controller, HX85200 series, targeting high-end AMOLED notebook at CES 2024, the largest consumer electronics show in Las Vegas, U.S.A., from January 9 – 12, 2024. Over the past few years, in-cell TDDI has been proven the mainstream technology as it provides integrated cutting-edge display and touch features that substantially simplify the touch module supply chain at superior cost advantages. Himax has excelled in the in-cell TDDI technology, providing the most comprehensive TDDI offerings...

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Day: December 18, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice